三生国健：第三季度净利润2.09亿元 同比增长101.41%

Core Viewpoint - The company reported significant growth in both revenue and net profit for the third quarter and the first three quarters of the year, driven by collaboration projects and operational efficiency improvements [1] Financial Performance - Q3 revenue reached 474 million yuan, representing a year-on-year increase of 38.27% [1] - Q3 net profit was 209 million yuan, showing a year-on-year growth of 101.41% [1] - Revenue for the first three quarters totaled 1.116 billion yuan, up 18.80% year-on-year [1] - Net profit for the first three quarters amounted to 399 million yuan, reflecting a year-on-year increase of 71.15% [1] Business Drivers - The growth in revenue is attributed to licensing income from collaboration projects with Shenyang Sansheng Pharmaceutical Co., Ltd. and an increase in CDMO (Contract Development and Manufacturing Organization) business [1] - The company has continued to optimize management efficiency, leading to a further reduction in expense ratios [1] Overall Performance Metrics - The report indicates that all key performance indicators, including total revenue, total profit, net profit attributable to shareholders, net profit excluding non-recurring gains and losses, basic earnings per share, and diluted earnings per share, have increased compared to the same period last year [1]